Associate/Full Professor, USC, Los Angeles


Up ]

Associate/Full Professor Position

The University of Southern California Department of Pharmaceutical Sciences ( invites applications for an associate/ full professor position. The successful candidate must provide an established research program that complements the existing departmental strengths in modern drug delivery and targeting, and, preferably, includes pharmacokinetic and pharmacodynamic components. The current research programs in the department draw upon expertise in epithelial cell biology, membrane trafficking, molecular modeling, molecular pharmacology, and pharmacokinetic imaging. Teaching in both Pharm.D. and graduate programs is required.

The University of Southern California offers exciting opportunities for multidisciplinary and translational research collaborations, including an NCI designated Comprehensive Cancer Center, an NIH sponsored Liver Center, Program Projects in Biomedical Engineering including PK/PD modeling, a Pharmacogenetics Network Grant, and centers of excellence in diabetes, HIV and neurogenetics. Opportunities also exist to establish linkage with the university-wide genomics initiative as well as to accelerate the school's effort to move forward into the pharmacogenomic era.

Applications should include: a current C.V., a list of at least three references, reprints of five peer-reviewed articles, and a transmittal letter explaining the candidate's views on how this position would be consistent with the candidate's approach to research and education. Review of applications begins immediately, and will continue until the position is filled. 

Address all correspondence to Wei-Chiang Shen, Ph.D., Chair, Pharmaceutical Sciences Search Committee, University of Southern California School of Pharmacy, 1985 Zonal Avenue, Los Angeles CA 90089-9121, email: The University of Southern California is an Equal  Opportunity/Affirmative Action Employer and encourages applications from women and minorities, and provides reasonable accommodation to individuals with known disabilities.

Last updated: February 05, 2002

Comments to these pages to the site manager